OLD Republic International Corp Has $36.37 Million Stock Holdings in Cardinal Health, Inc. $CAH

OLD Republic International Corp lessened its position in Cardinal Health, Inc. (NYSE:CAH) by 52.8% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 177,000 shares of the company’s stock after selling 198,000 shares during the period. OLD Republic International Corp owned about 0.08% of Cardinal Health worth $36,374,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in CAH. Wellington Management Group LLP boosted its stake in shares of Cardinal Health by 153.2% in the 3rd quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock valued at $911,010,000 after purchasing an additional 3,511,579 shares in the last quarter. Holocene Advisors LP boosted its stake in shares of Cardinal Health by 141.4% in the 3rd quarter. Holocene Advisors LP now owns 1,926,170 shares of the company’s stock valued at $302,332,000 after purchasing an additional 1,128,358 shares in the last quarter. Barclays PLC boosted its stake in shares of Cardinal Health by 109.3% in the 3rd quarter. Barclays PLC now owns 1,584,214 shares of the company’s stock valued at $248,658,000 after purchasing an additional 827,446 shares in the last quarter. SG Americas Securities LLC boosted its stake in shares of Cardinal Health by 3,829.1% in the 4th quarter. SG Americas Securities LLC now owns 727,511 shares of the company’s stock valued at $149,504,000 after purchasing an additional 708,995 shares in the last quarter. Finally, Victory Capital Management Inc. raised its holdings in shares of Cardinal Health by 44.9% in the third quarter. Victory Capital Management Inc. now owns 2,284,115 shares of the company’s stock valued at $352,165,000 after buying an additional 707,495 shares during the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on CAH shares. Argus lifted their price target on Cardinal Health from $232.00 to $248.00 and gave the company a “buy” rating in a report on Wednesday, February 11th. Morgan Stanley lifted their price target on Cardinal Health from $245.00 to $255.00 and gave the company an “overweight” rating in a report on Tuesday, April 28th. TD Cowen lifted their price target on Cardinal Health from $251.00 to $255.00 and gave the company a “buy” rating in a report on Friday, May 1st. Wells Fargo & Company cut their price target on Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a report on Friday, May 1st. Finally, Weiss Ratings cut Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a report on Tuesday. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, Cardinal Health has an average rating of “Moderate Buy” and a consensus target price of $241.80.

Cardinal Health Trading Down 0.1%

Shares of NYSE:CAH opened at $200.42 on Friday. The stock has a market capitalization of $46.94 billion, a P/E ratio of 30.64, a P/E/G ratio of 1.19 and a beta of 0.53. Cardinal Health, Inc. has a 1-year low of $137.75 and a 1-year high of $233.60. The business has a 50-day moving average price of $205.21 and a two-hundred day moving average price of $208.69.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, topping the consensus estimate of $2.79 by $0.38. The firm had revenue of $60.94 billion during the quarter, compared to analysts’ expectations of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The company’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same period in the previous year, the business posted $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, equities analysts predict that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be issued a dividend of $0.5158 per share. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $2.06 annualized dividend and a yield of 1.0%. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio (DPR) is presently 31.19%.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.